NQO1 and familial dilated cardiomyopathy: DCM has been recognised as an inhibitor of two targets, NQO1 and VKORC1, in the recycling of vitamin K metabolism (Fig. 3a).10 However, the cell-specific expression patterns of NQO1 and VKORC1 in AECs remain unclear.